<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRA</journal-id>
<journal-id journal-id-type="hwp">spjra</journal-id>
<journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id>
<journal-title>Journal of the Renin-Angiotensin-Aldosterone System</journal-title>
<issn pub-type="ppub">1470-3203</issn>
<issn pub-type="epub">1752-8976</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1470320312440903</article-id>
<article-id pub-id-type="publisher-id">10.1177_1470320312440903</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>AGT</italic> M235T polymorphism contributes to risk of preeclampsia: evidence from a meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ni</surname><given-names>Shanshan</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312440903">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Yanyan</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312440903">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Deng</surname><given-names>Yulin</given-names></name>
<xref ref-type="aff" rid="aff2-1470320312440903">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gong</surname><given-names>Yunhui</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312440903">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname><given-names>Juan</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312440903">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bai</surname><given-names>Yi</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312440903">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhou</surname><given-names>Rong</given-names></name>
<xref ref-type="aff" rid="aff1-1470320312440903">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1470320312440903"><label>1</label>Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, PR China</aff>
<aff id="aff2-1470320312440903"><label>2</label>Chinese Evidence-Based Medicine Centre, Sichuan University, PR China</aff>
<author-notes>
<corresp id="corresp1-1470320312440903">Rong Zhou, Department of Obstetrics and Gynaecology, NO.20 section 3 of Ren Min Nan road, West China Second University Hospital, Sichuan University, Chengdu 610041, PR China. Email: <email>zhourong_hx@scu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<fpage>379</fpage>
<lpage>386</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Objective: Preeclampsia a hypertensive disorder of pregnancy that mainly manifests as high blood pressure and proteinuria. Angiotensinogen (AGT) plays important roles in the regulation of blood pressure. The purpose of this study was to investigate the relationship between <italic>AGT</italic> M235T polymorphism and risk of preeclampsia using a meta-analysis. Methods: In this meta-analysis, 22 studies were selected by searching PubMed, EMBASE, ISI and CNKI databases up to October 2011. Crude odds ratios with corresponding 95% confidence intervals were used to evaluate the association between the <italic>AGT</italic> M235T polymorphism and risk of preeclampsia. Subgroup analyses were conducted by ethnicity and parity. Results: The TT genotype of the <italic>AGT</italic> M235T polymorphism was associated with elevated risk of preeclampsia in the overall analysis. In subgroup analysis according to ethnicity, increased risks were also found in Caucasians. After stratification based on parity, the excess risk was found in multigravida. Conclusions: These results showed that the TT genotype may play critical roles in the development of preeclampsia.</p>
</abstract>
<kwd-group>
<kwd>Angiotensinogen</kwd>
<kwd>polymorphism</kwd>
<kwd>meta-analysis</kwd>
<kwd>preeclampsia</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1470320312440903" sec-type="intro">
<title>Introduction</title>
<p>Preeclampsia (PE) is a hypertensive disorder of pregnancy. This disease manifests as high blood pressure and proteinuria, may affect multiple systems of the body and contribute to adverse pregnancy outcomes including maternal death, preterm birth, fetal intrauterine growth restriction and fetal death. According to the 2005 World Health Organization report, PE occurs in approximately 3–5% of pregnancies worldwide.<sup><xref ref-type="bibr" rid="bibr1-1470320312440903">1</xref></sup> PE/eclampsia leads to 10–15% of direct maternal deaths, and the incidence is higher in developing countries than in developed countries.<sup><xref ref-type="bibr" rid="bibr2-1470320312440903">2</xref></sup> Although the etiology of PE is still unclear, its familial nature has been demonstrated. First-degree relatives of preeclamptic women were shown to have higher rates of getting PE than matched controls regardless of populations.<sup><xref ref-type="bibr" rid="bibr3-1470320312440903">3</xref></sup> To clarify the genetic nature of PE, a range of studies have been conducted to investigate the linkage between genes (e.g. angiotensinogen) and PE.</p>
<p>Angiotensinogen (AGT) is the precursor of angiotensin II, that plays crucial roles in the regulation of blood pressure. The <italic>AGT</italic> gene, located on chromosome 1, has been reported to be related to the development of PE and essential hypertension.<sup><xref ref-type="bibr" rid="bibr4-1470320312440903">4</xref><xref ref-type="bibr" rid="bibr5-1470320312440903"/>-<xref ref-type="bibr" rid="bibr6-1470320312440903">6</xref></sup> A common polymorphism <italic>AGT</italic> M235T (the substitution of threonine [Thr] for methionine [Met] at codon 235) was first identified in 1992,<sup><xref ref-type="bibr" rid="bibr7-1470320312440903">7</xref></sup> and the Thr235 variant has been reported to be associated with higher AGT levels and abnormal remodeling of the uterine spiral arteries, which is an early cause of PE.<sup><xref ref-type="bibr" rid="bibr8-1470320312440903">8</xref><xref ref-type="bibr" rid="bibr9-1470320312440903"/>-<xref ref-type="bibr" rid="bibr10-1470320312440903">10</xref></sup></p>
<p>To date, large numbers of epidemiological studies have been performed to examine the relationship between the <italic>AGT</italic> M235T polymorphism and risk of PE.<sup><xref ref-type="bibr" rid="bibr8-1470320312440903">8</xref>,<xref ref-type="bibr" rid="bibr11-1470320312440903">11</xref><xref ref-type="bibr" rid="bibr12-1470320312440903"/><xref ref-type="bibr" rid="bibr13-1470320312440903"/><xref ref-type="bibr" rid="bibr14-1470320312440903"/><xref ref-type="bibr" rid="bibr15-1470320312440903"/>-<xref ref-type="bibr" rid="bibr16-1470320312440903">16</xref></sup> The results, however, were controversial in different studies. Some investigators reported that the <italic>AGT</italic> M235T polymorphism was associated with the risk of PE in Caucasian<sup><xref ref-type="bibr" rid="bibr5-1470320312440903">5</xref>,<xref ref-type="bibr" rid="bibr17-1470320312440903">17</xref>,<xref ref-type="bibr" rid="bibr18-1470320312440903">18</xref></sup> and Japanese patients.<sup><xref ref-type="bibr" rid="bibr19-1470320312440903">19</xref></sup> In contrast, other investigators have reported that the <italic>AGT</italic> M235T polymorphism was not a risk factor for the development of PE in Africans,<sup><xref ref-type="bibr" rid="bibr20-1470320312440903">20</xref></sup> Asians,<sup><xref ref-type="bibr" rid="bibr21-1470320312440903">21</xref><xref ref-type="bibr" rid="bibr22-1470320312440903"/><xref ref-type="bibr" rid="bibr23-1470320312440903"/>-<xref ref-type="bibr" rid="bibr24-1470320312440903">24</xref></sup> and Caucasians.<sup><xref ref-type="bibr" rid="bibr25-1470320312440903">25</xref><xref ref-type="bibr" rid="bibr26-1470320312440903"/>-<xref ref-type="bibr" rid="bibr27-1470320312440903">27</xref></sup> We have conducted a meta-analysis to provide strong evidence of the effects of the <italic>AGT</italic> M235T polymorphism on PE risk, with much greater sample size.</p>
</sec>
<sec id="section2-1470320312440903" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-1470320312440903">
<title>Selection of published studies</title>
<p>We searched all publications of PubMed, EMBASE, ISI Web of Science and CNKI databases via the internet without language limitation. The following terms were used as searching keywords: [(“polymorphism” or “polymorphisms” or “variant”) and (“AGT” or “angiotensinogen”) and (“pre-eclampsia” or “preeclampsia”)]. The literature search was performed up to October 2011. Two authors (Ni and Zhang) conducted the retrieval work independently.</p>
<p>The inclusion criteria were: (a) case-control and case-cohort studies that explored the association between the <italic>AGT</italic> M235T polymorphism and risk of PE/eclampsia; (b) presenting original data for the calculation of odds ratios (ORs) with corresponding 95% confidence intervals (95%CIs). We excluded studies with smaller sample size if duplicate publications were reported by the same group.</p>
<p>The definition of PE was described as following the criteria according to the report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy.<sup><xref ref-type="bibr" rid="bibr28-1470320312440903">28</xref></sup> Women with eclampsia and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome were included.</p>
</sec>
<sec id="section4-1470320312440903">
<title>Data extraction</title>
<p>Two authors (Ni and Zhang) extracted data from the selected studies independently. If the data they obtained were different, the third author (Zhou) would check the data and a final decision would be made following discussion among the three authors. The following information was collected from each study: the surname of the first author; country; year of publication; study design; ethnicity; matching variables; population evaluated; number of cases and controls; genotyping methods; quality control for genotyping assay; allele frequencies and genotype distribution in cases and controls (if the data were not available, we computed according to the corresponding genotyping frequencies).</p>
</sec>
<sec id="section5-1470320312440903">
<title>Statistical analysis</title>
<p>ORs with corresponding 95% CIs were used to assess the effect of the <italic>AGT</italic> M235T polymorphism on PE risk (MT versus MM, TT versus MM, TT versus MM/MT, and MT/TT versus MM). We evaluated the between-study heterogeneity first using the Q-test and <italic>I</italic><sup>2</sup> statistics.<sup><xref ref-type="bibr" rid="bibr29-1470320312440903">29</xref>,<xref ref-type="bibr" rid="bibr30-1470320312440903">30</xref></sup> If the <italic>p</italic>-value for the Q-test was &gt;0.10 and <italic>I</italic><sup>2</sup> &lt;50%, the fixed-effects model (the Mantel–Haenszel method) was carried out to estimate the summarized ORs. On the contrary, if the <italic>p</italic>-value for the Q-test was ≤0.10 or <italic>I</italic><sup>2</sup> ≥50%, the random-effects model (the DerSimonian and Laird method) was carried out to estimate the summarized ORs, and logistic meta-regression was used to investigate potential sources of heterogeneity across studies. Subgroup analyses were conducted based on ethnicity (Asian, Caucasian, African and mixed) and parity (primiparity versus multiparity). Funnel plot and Egger’s regression asymmetry test were performed to assess publication bias. All analyses were done in STATA software, version 10.0 (STATA Corp., College Station, TX, USA).</p>
</sec>
</sec>
<sec id="section6-1470320312440903" sec-type="results">
<title>Results</title>
<sec id="section7-1470320312440903">
<title>Characteristics of studies</title>
<p>In total, 236 articles were found after searching the databases mentioned above; 135 duplicated articles were excluded, leaving 101 studies. Of these, 44 studies were excluded after screening the title or abstract (13 were not the <italic>AGT</italic> M235T polymorphism; 23 were not preeclampsia; five were review articles; and no data were available in three). After retrieving the full-text articles, 35 were excluded (eight were not preeclampsia; six were not the <italic>AGT</italic> M235T polymorphism; five were review articles; 15 were no available data and one was overlapped data). Finally, 22 studies were selected in this meta-analysis with 2367 cases and 5167 controls (<xref ref-type="fig" rid="fig1-1470320312440903">Figure 1</xref>; <xref ref-type="table" rid="table1-1470320312440903">Table 1</xref>). Since the genotype distributions were presented in different populations in three studies, they were considered separately in subgroup analysis according to ethnicity.<sup><xref ref-type="bibr" rid="bibr5-1470320312440903">5</xref>,<xref ref-type="bibr" rid="bibr15-1470320312440903">15</xref>,<xref ref-type="bibr" rid="bibr21-1470320312440903">21</xref></sup> There were 10 studies in Asians, 11 studies in Caucasians, two studies in Africans, and two studies in mixed populations containing more than one ethnicity.</p>
<fig id="fig1-1470320312440903" position="float">
<label>Figure 1.</label>
<caption><p>Flow Diagram</p></caption>
<graphic xlink:href="10.1177_1470320312440903-fig1.tif"/>
</fig>
<table-wrap id="table1-1470320312440903" position="float">
<label>Table 1.</label>
<caption><p>Information of published studies of the association between the <italic>AGT</italic> M235T polymorphism and preeclampsia</p></caption>
<graphic alternate-form-of="table1-1470320312440903" xlink:href="10.1177_1470320312440903-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study (first author)</th>
<th align="left">Year of publication</th>
<th align="left">Country</th>
<th align="left">Sample size (cases/controls)</th>
<th align="left">Ethnicity</th>
<th align="left">study design</th>
<th align="left">population evaluated</th>
<th align="left">Genotyping methods</th>
<th align="left">Matching criteria</th>
<th align="left">The frequency of T allele in controls</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ward<sup><xref ref-type="bibr" rid="bibr5-1470320312440903">5</xref></sup></td>
<td>1993</td>
<td>USA</td>
<td>63/571</td>
<td>Caucasian</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASOH</td>
<td>-</td>
<td>0.41</td>
</tr>
<tr>
<td>Ward<sup><xref ref-type="bibr" rid="bibr5-1470320312440903">5</xref></sup></td>
<td>1993</td>
<td>Japan</td>
<td>18/80</td>
<td>Japanese</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASOH</td>
<td>-</td>
<td>0.71</td>
</tr>
<tr>
<td>Guo<sup><xref ref-type="bibr" rid="bibr21-1470320312440903">21</xref></sup></td>
<td>1997</td>
<td>Australia</td>
<td>106/81</td>
<td>Caucasian</td>
<td>Case-control</td>
<td>population</td>
<td>RFLP, ASA</td>
<td>-</td>
<td>0.38</td>
</tr>
<tr>
<td>Guo<sup><xref ref-type="bibr" rid="bibr21-1470320312440903">21</xref></sup></td>
<td>1997</td>
<td>China</td>
<td>72/48</td>
<td>Chinese</td>
<td>Case-control</td>
<td>population</td>
<td>RFLP, ASA</td>
<td>-</td>
<td>0.75</td>
</tr>
<tr>
<td>Kobashi<sup><xref ref-type="bibr" rid="bibr19-1470320312440903">19</xref></sup></td>
<td>1999</td>
<td>Japan</td>
<td>90/381</td>
<td>Japanese</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASA</td>
<td>-</td>
<td>0.76</td>
</tr>
<tr>
<td>Morgan<sup><xref ref-type="bibr" rid="bibr9-1470320312440903">9</xref></sup></td>
<td>1999</td>
<td>UK</td>
<td>43/84</td>
<td>Caucasians</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASOH</td>
<td>Parity</td>
<td>0.48</td>
</tr>
<tr>
<td>Suzuki<sup><xref ref-type="bibr" rid="bibr23-1470320312440903">23</xref></sup></td>
<td>1999</td>
<td>Japan</td>
<td>9/280</td>
<td>Japanese</td>
<td>Cohort</td>
<td>hospital</td>
<td>ASOH</td>
<td>Age, parity and BMI</td>
<td>0.80</td>
</tr>
<tr>
<td>Bashford<sup><xref ref-type="bibr" rid="bibr26-1470320312440903">26</xref></sup></td>
<td>2001</td>
<td>USA</td>
<td>68/50</td>
<td>Hispanic</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASOH</td>
<td>Age</td>
<td>0.70</td>
</tr>
<tr>
<td>Procopciuc<sup><xref ref-type="bibr" rid="bibr18-1470320312440903">18</xref></sup></td>
<td>2002</td>
<td>Romania</td>
<td>13/6</td>
<td>Caucasian</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>-</td>
<td>0.33</td>
</tr>
<tr>
<td>Bouba<sup><xref ref-type="bibr" rid="bibr17-1470320312440903">17</xref></sup></td>
<td>2003</td>
<td>Greece</td>
<td>41/102</td>
<td>Hellenic</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>Ethnicity and age</td>
<td>0.40</td>
</tr>
<tr>
<td>Choi<sup><xref ref-type="bibr" rid="bibr22-1470320312440903">22</xref></sup></td>
<td>2004</td>
<td>South Korea</td>
<td>100/100</td>
<td>Korean</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>Age</td>
<td>0.78</td>
</tr>
<tr>
<td>Kim<sup><xref ref-type="bibr" rid="bibr24-1470320312440903">24</xref></sup></td>
<td>2004</td>
<td>South Korea</td>
<td>87/88</td>
<td>Korean</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>Age and parity</td>
<td>0.58</td>
</tr>
<tr>
<td>Levesque<sup><xref ref-type="bibr" rid="bibr36-1470320312440903">36</xref></sup></td>
<td>2004</td>
<td>Canada</td>
<td>169/643</td>
<td>Caucasian</td>
<td>Cohort</td>
<td>population</td>
<td>ASA</td>
<td>Maternal age, gestational age at delivery, BMI, parity and month of the year at delivery</td>
<td>0.41</td>
</tr>
<tr>
<td>Roberts<sup><xref ref-type="bibr" rid="bibr20-1470320312440903">20</xref></sup></td>
<td>2004</td>
<td>South Africa</td>
<td>391/338</td>
<td>Black South African</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASA</td>
<td>Age and parity</td>
<td>0.92</td>
</tr>
<tr>
<td>Tempfer<sup><xref ref-type="bibr" rid="bibr27-1470320312440903">27</xref></sup></td>
<td>2004</td>
<td>Austria</td>
<td>24/24</td>
<td>Caucasian</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASOH</td>
<td>Gestational age and parity</td>
<td>0.56</td>
</tr>
<tr>
<td>Hillermann<sup><xref ref-type="bibr" rid="bibr37-1470320312440903">37</xref></sup></td>
<td>2005</td>
<td>South Africa</td>
<td>49/45</td>
<td>Colored South African</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>-</td>
<td>0.82</td>
</tr>
<tr>
<td>Wang<sup><xref ref-type="bibr" rid="bibr38-1470320312440903">38</xref></sup></td>
<td>2006</td>
<td>USA</td>
<td>121/1001</td>
<td>Mixed</td>
<td>Case-control</td>
<td>hospital</td>
<td>Taqman</td>
<td>Age</td>
<td>0.15</td>
</tr>
<tr>
<td>Benedetto<sup><xref ref-type="bibr" rid="bibr16-1470320312440903">16</xref></sup></td>
<td>2007</td>
<td>Italy</td>
<td>120/103</td>
<td>Caucasian</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>Age</td>
<td>0.49</td>
</tr>
<tr>
<td>Jenkins<sup><xref ref-type="bibr" rid="bibr15-1470320312440903">15</xref></sup></td>
<td>2008</td>
<td>USA</td>
<td>18/202</td>
<td>African American</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>-</td>
<td>0.79</td>
</tr>
<tr>
<td>Jenkins<sup><xref ref-type="bibr" rid="bibr15-1470320312440903">15</xref></sup></td>
<td>2008</td>
<td>USA</td>
<td>152/238</td>
<td>Caucasian</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>-</td>
<td>0.41</td>
</tr>
<tr>
<td>Knyrim<sup><xref ref-type="bibr" rid="bibr14-1470320312440903">14</xref></sup></td>
<td>2008</td>
<td>Germany</td>
<td>67/100</td>
<td>Caucasian</td>
<td>Cohort</td>
<td>hospital</td>
<td>SSCP,RFLP</td>
<td>-</td>
<td>0.41</td>
</tr>
<tr>
<td>Yoshida<sup><xref ref-type="bibr" rid="bibr13-1470320312440903">13</xref></sup></td>
<td>2008</td>
<td>Japan</td>
<td>52/113</td>
<td>Japanese</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>Age and BMI</td>
<td>0.68</td>
</tr>
<tr>
<td>Dissanayake<sup><xref ref-type="bibr" rid="bibr12-1470320312440903">12</xref></sup></td>
<td>2009</td>
<td>Sri Lanka</td>
<td>174/171</td>
<td>Sri Lankan</td>
<td>Case-control</td>
<td>hospital</td>
<td>ASOH</td>
<td>Ethnicity, age and BMI</td>
<td>0.61</td>
</tr>
<tr>
<td>Aggarwal<sup><xref ref-type="bibr" rid="bibr11-1470320312440903">11</xref></sup></td>
<td>2010</td>
<td>India</td>
<td>120/118</td>
<td>Indian</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>-</td>
<td>0.85</td>
</tr>
<tr>
<td>Aggarwal<sup><xref ref-type="bibr" rid="bibr8-1470320312440903">8</xref></sup></td>
<td>2011</td>
<td>India</td>
<td>200/200</td>
<td>Indian</td>
<td>Case-control</td>
<td>hospital</td>
<td>RFLP</td>
<td>Age</td>
<td>0.50</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1470320312440903">
<p>ASOH, allele-specific oligonucleotide hybridization; ASA, allele-specific amplification; RFLP, polymerase chain reaction-restriction fragment length polymorphism; SSCP, sub-sequent single-strand conformation polymorphism analysis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Several genotyping methods were used, such as allele-speciﬁc oligonucleotide hybridization, allele-speciﬁc ampliﬁcation, polymerase chain reaction-restriction fragment length polymorphism and Taqman assay. Only nine studies, however, reported quality control for genotyping assay, including positive control, negative control, random replication and sequencing. The genotype distributions in controls were consistent with Hardy-Weinberg equilibrium (HWE) in all except three studies.<sup><xref ref-type="bibr" rid="bibr8-1470320312440903">8</xref>,<xref ref-type="bibr" rid="bibr26-1470320312440903">26</xref>,<xref ref-type="bibr" rid="bibr27-1470320312440903">27</xref></sup></p>
</sec>
<sec id="section8-1470320312440903">
<title>Main results</title>
<p>The TT genotype of the <italic>AGT</italic> M235T polymorphism was associated with a significantly increased risk of PE in overall analysis (TT versus MM: OR=1.33, 95%CI, 1.09–1.61; TT versus MM/MT: OR=1.30, 95%CI, 1.02–1.67, respectively). In subgroup analysis according to ethnicity, significantly increased risks were also found in Caucasians (MT versus MM: OR=1.32, 95%CI, 1.08–1.62; TT versus MM: OR=1.43, 95%CI, 1.12–1.83; TT versus MM/MT: OR=1.25, 95%CI, 1.02–1.54; and MT/TT versus MM: OR=1.36, 95%CI, 1.12–1.64, respectively) but not in Africans, Asians and mixed populations (<xref ref-type="fig" rid="fig2-1470320312440903">Figures 2</xref> and <xref ref-type="fig" rid="fig3-1470320312440903">3</xref>). After stratification based on parity, the excess risk was found in multigravida (TT versus MM/MT: OR=1.95; 95%CI, 1.10–3.47) but not in primigravida (<xref ref-type="table" rid="table2-1470320312440903">Table 2</xref>).</p>
<fig id="fig2-1470320312440903" position="float">
<label>Figure 2.</label>
<caption><p>Results reflected relationship between the <italic>AGT</italic> M235T polymorphism and preeclampsia in different ethnic groups. ORs for the outcome compared the T235T genotype vs. the M235M. The size of the square is proportional to the percent weight of study, and horizontal line represents the 95% CI.</p></caption>
<graphic xlink:href="10.1177_1470320312440903-fig2.tif"/>
</fig>
<fig id="fig3-1470320312440903" position="float">
<label>Figure 3.</label>
<caption><p>Results reflected relationship between the AGT M235T polymorphism and preeclampsia in different ethnic groups. ORs for the outcome compared the M235T/ T235T genotype vs. the M235M. The size of the square is proportional to the percent weight of study, and horizontal line represents the 95% CI.</p></caption>
<graphic xlink:href="10.1177_1470320312440903-fig3.tif"/>
</fig>
<table-wrap id="table2-1470320312440903" position="float">
<label>Table 2.</label>
<caption><p>Stratified analyses of the <italic>AGT</italic> M235T polymorphism on PE risk</p></caption>
<graphic alternate-form-of="table2-1470320312440903" xlink:href="10.1177_1470320312440903-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left"><italic>n</italic></th>
<th align="left">Cases/controls</th>
<th align="left" colspan="2">MT versus MM<hr/></th>
<th align="left" colspan="2">TT versus MM<hr/></th>
<th align="left" colspan="2">TT versus MM/MT<hr/></th>
<th align="left" colspan="2">MT/TT versus MM<hr/></th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="left">OR (95%CI)</th>
<th align="left"><italic>p</italic>
<sub>heterogeneity</sub></th>
<th align="left">OR (95%CI)</th>
<th align="left"><italic>p</italic>
<sub>heterogeneity</sub></th>
<th align="left">OR (95%CI)</th>
<th align="left"><italic>p</italic>
<sub>heterogeneity</sub></th>
<th align="left">OR (95%CI)</th>
<th align="left"><italic>p</italic>
<sub>heterogeneity</sub></th>
</tr>
</thead>
<tbody>
<tr>
<td>Total</td>
<td>22</td>
<td>2367/5167</td>
<td>1.09</td>
<td>0.10</td>
<td><bold>1.33</bold></td>
<td>0.26</td>
<td><bold>1.30</bold></td>
<td>&lt; 0.001</td>
<td>1.15</td>
<td>0.12</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>(0.93–1.27)</td>
<td/>
<td><bold>(1.09–1.61)</bold></td>
<td/>
<td><bold>(1.02–1.67)</bold> <sup><xref ref-type="table-fn" rid="table-fn2-1470320312440903">a</xref></sup></td>
<td/>
<td>(0.99–1.33)</td>
<td/>
</tr>
<tr>
<td colspan="11">Ethnicities</td>
</tr>
<tr>
<td>African</td>
<td>2</td>
<td>409/540</td>
<td>0.40</td>
<td>0.44</td>
<td>0.61</td>
<td>0.31</td>
<td>1.21</td>
<td>0.29</td>
<td>0.54</td>
<td>0.35</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>(0.08–2.00)</td>
<td/>
<td>(0.14<bold>–</bold>2.62)</td>
<td/>
<td>(0.83–1.77)</td>
<td/>
<td>(0.12–2.40)</td>
<td/>
</tr>
<tr>
<td>Asian</td>
<td>10</td>
<td>922/1579</td>
<td>0.82</td>
<td>0.19</td>
<td>1.28</td>
<td>0.42</td>
<td>1.36</td>
<td>&lt; 0.001</td>
<td>0.93</td>
<td>0.26</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>(0.60–1.12)</td>
<td/>
<td>(0.91<bold>–</bold>1.79)</td>
<td/>
<td>(0.80–2.33) <sup><xref ref-type="table-fn" rid="table-fn2-1470320312440903">a</xref></sup></td>
<td/>
<td>(0.69–1.25)</td>
<td/>
</tr>
<tr>
<td>Caucasian</td>
<td>11</td>
<td>866/2002</td>
<td><bold>1.32</bold></td>
<td>0.46</td>
<td><bold>1.43</bold></td>
<td>0.11</td>
<td><bold>1.25</bold></td>
<td>0.29</td>
<td><bold>1.36</bold></td>
<td>0.31</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td><bold>(1.08–1.62)</bold></td>
<td/>
<td><bold>(1.12–1.83)</bold></td>
<td/>
<td><bold>(1.02–1.54)</bold></td>
<td/>
<td><bold>(1.12–1.64)</bold></td>
<td/>
</tr>
<tr>
<td>Mixed</td>
<td>2</td>
<td>170/1046</td>
<td>0.80</td>
<td>0.71</td>
<td>0.73</td>
<td>0.95</td>
<td>1.07</td>
<td>0.56</td>
<td>0.80</td>
<td>0.90</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>(0.51–1.25)</td>
<td/>
<td>(0.23–2.31)</td>
<td/>
<td>(0.51–2.26)</td>
<td/>
<td>(0.52–1.24)</td>
<td/>
</tr>
<tr>
<td>Primigravida</td>
<td>4</td>
<td>279/966</td>
<td>1.33</td>
<td>0.26</td>
<td>1.35</td>
<td>0.97</td>
<td>1.40</td>
<td>0.003</td>
<td>1.36</td>
<td>1.00</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>(0.92–1.90)</td>
<td/>
<td>(0.86–2.11)</td>
<td/>
<td>(0.55–3.56) <sup><xref ref-type="table-fn" rid="table-fn2-1470320312440903">a</xref></sup></td>
<td/>
<td>(0.96–1.91)</td>
<td/>
</tr>
<tr>
<td>Multigravida</td>
<td>2</td>
<td>76/264</td>
<td>1.07</td>
<td>0.57</td>
<td>1.65</td>
<td>0.30</td>
<td><bold>1.95</bold></td>
<td>0.17</td>
<td>1.20</td>
<td>0.36</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>(0.38–3.01)</td>
<td/>
<td>(0.60–4.52)</td>
<td/>
<td><bold>(1.10–3.47)</bold></td>
<td/>
<td>(0.46–3.16)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1470320312440903">
<label>a</label>
<p>Random-effects model was used.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section9-1470320312440903">
<title>Heterogeneity analysis and publication bias</title>
<p>Obvious heterogeneity between studies was present in the overall comparisons (TT versus MM/MT: <italic>p</italic>&lt;0.001). Meta-regression analysis was used to explore the sources of the heterogeneity. However, none of the predetermined potential sources (ethnicity, genotyping methods, sample size, and HWE) could account for the heterogeneity. Funnel plot and Egger’s regression asymmetry test were used to estimate publication bias, and we failed to find any bias in all comparisons.</p>
</sec>
</sec>
<sec id="section10-1470320312440903" sec-type="discussion">
<title>Discussion</title>
<p>In this meta-analysis, 22 studies with 2367 cases and 5167 controls were selected, and the TT genotype of the <italic>AGT</italic> M235T polymorphism was found to be associated with an increased risk of PE. Similar positive results were also observed in Caucasians and multigravida women. Our results were in consistent with previous meta-analyses. In 2007, Medica et al. performed a meta-analysis involving 13 studies with 1128 patients and 2278 controls, and found that the TT genotype had a 1.54-fold risk of developing PE compared with the MM/MT genotypes under a random-effects model (OR=1.54, 95%CI, 1.12–2.11).<sup><xref ref-type="bibr" rid="bibr31-1470320312440903">31</xref></sup> In 2008, Zafarmand et al. performed another meta-analysis involving 17 studies with 1446 patients and 3829 controls, and found that women carrying the TT genotype were 62% more likely to develop PE compared with those carrying the MM genotype (OR=1.62, 95%CI, 1.12–2.33).<sup><xref ref-type="bibr" rid="bibr32-1470320312440903">32</xref></sup> These findings indicate that <italic>AGT</italic> may be a candidate susceptibility gene in the development of PE.</p>
<p>Subgroup analysis according to ethnicity showed that the excess risk of the <italic>AGT</italic> M235T polymorphism was found in Caucasians but not in Africans, Asians and mixed populations. This result was similar to the report by Zafarmand et al., who found that the TT genotype of the <italic>AGT</italic> M235T polymorphism was significantly associated with a high risk of PE in Caucasians but not in Hispanics or Black Africans.<sup><xref ref-type="bibr" rid="bibr32-1470320312440903">32</xref></sup> There are a number of possible explanations for the ethnic differences. The distribution of the <italic>AGT</italic> M235T polymorphism varied widely among different ethnic groups. The mean frequency of the 235T allele in controls was 0.85 in Africans (0.79–0.92), 0.70 in Asians (0.50–0.85), and 0.45 in Caucasians (0.33–0.70). The high frequency of the 235T allele in Africans and Asians makes it difficult to yield positive results, especially when the association is marginal. Moreover, the sample size is relatively small, and may not provide enough statistical power to detect the effect of the <italic>AGT</italic> M235T polymorphism on PE risk, particularly in Africans, with only 409 cases and 540 controls eligible in this meta-analysis. Therefore, further studies with larger population samples are necessary to confirm these findings.</p>
<p>Emerging evidence has shown that the pathophysiology of PE is different in primigravida and multigravida.<sup><xref ref-type="bibr" rid="bibr33-1470320312440903">33</xref>,<xref ref-type="bibr" rid="bibr34-1470320312440903">34</xref></sup> Therefore, subgroup analysis based on parity was also conducted. We found that the TT genotype of the <italic>AGT</italic> M235T polymorphism was more likely to develop PE in multigravida rather than in primigravida. AGT is one of the key effectors in the regulation of blood pressure. Multigravida with PE had an earlier increase in blood pressure than primigravida,<sup><xref ref-type="bibr" rid="bibr34-1470320312440903">34</xref></sup> which may contribute to the positive result of the <italic>AGT</italic> M235T polymorphism in multigravida. Replication association studies would be of great value to verify this result because of the very limited sample size in this study.</p>
<p>Although the exact mechanism of PE remains unclear, it is widely accepted that AGT plays critical roles in its development. AGT is a renin substrate, which is a major molecule in the renin–angiotensin– aldosterone system (RAAS), with the function of regulating blood pressure. The AGT levels among hypertensive individuals are related to the variants of <italic>AGT</italic> gene.<sup><xref ref-type="bibr" rid="bibr7-1470320312440903">7</xref></sup> AGT 235T expression was elevated in decidual spiral arteries, and the T allele was associated with abnormal pregnancy-induced spiral artery remodeling, which caused atherotic changes and promoted the cascade of events resulting in PE.<sup><xref ref-type="bibr" rid="bibr9-1470320312440903">9</xref>,<xref ref-type="bibr" rid="bibr35-1470320312440903">35</xref></sup> Taken together, our findings that the <italic>AGT</italic> may be a risk factor for the development of PE are biologically plausible.</p>
<p>There are some limitations in our study. The obvious heterogeneity among studies was detected in one of the overall comparison models (TT versus MM/MT). Several possible variables including ethnicity, genotyping methods, sample size, and HWE were taken into consideration to account for the heterogeneity. However, none of these factors could explain this variation, suggesting unknown reasons may have biased the result. On the other hand, detailed information on the gene–gene and gene–environment interactions was not available, which may influence our comprehensive understanding about the genetic susceptibility to PE. Although these limitations existed in this study, no evidence of publication bias was present, indicating our results were reliable in methodology.</p>
<p>To conclude, this meta-analysis provides strong evidence that women carrying the TT genotype of the <italic>AGT</italic> M235T polymorphism had an elevated risk of developing PE, particularly in Caucasians and multiparous women. Further validation is warranted to determine the association in diverse ethnic groups. In addition, understanding the combination of genetic factors together with environmental exposures will increase our understanding of the etiology of PE.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This study was supported by National Natural Science Foundation of China [grant number 81170593]; the Office of Science &amp; Technology of Sichuan Province [grant number 2009SZ0149]; Ministry of Education of China [grant number 20110181110010]; and the Office of Science &amp; Technology of Chengdu City [grant number 10GGYB899SF-023].</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>The authors declare that there is no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1470320312440903">
<label>1.</label>
<citation citation-type="book">
<collab>WHO</collab>. <source>World health report: make every mother and child count</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>2005</year>, p.<fpage>63</fpage>.</citation>
</ref>
<ref id="bibr2-1470320312440903">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duley</surname><given-names>L</given-names></name>
</person-group>. <article-title>The global impact of pre-eclampsia and eclampsia</article-title>. <source>Semin Perinatol</source> <year>2009</year>; <volume>33</volume>: <fpage>130</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr3-1470320312440903">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ward</surname><given-names>K</given-names></name>
</person-group>. <article-title>Genetic factors in common obstetric disorders</article-title>. <source>Clin Obstet Gynecol</source> <year>2008</year>; <volume>51</volume>: <fpage>74</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr4-1470320312440903">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arngrimsson</surname><given-names>R</given-names></name>
<name><surname>Purandare</surname><given-names>S</given-names></name>
<name><surname>Connor</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Angiotensinogen: a candidate gene involved in preeclampsia?</article-title> <source>Nat Genet</source> <year>1993</year>; <volume>4</volume>: <fpage>114</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr5-1470320312440903">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ward</surname><given-names>K</given-names></name>
<name><surname>Hata</surname><given-names>A</given-names></name>
<name><surname>Jeunemaitre</surname><given-names>X</given-names></name><etal/>
</person-group>. <article-title>A molecular variant of angiotensinogen associated with preeclampsia</article-title>. <source>Nat Genet</source> <year>1993</year>; <volume>4</volume>: <fpage>59</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr6-1470320312440903">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jeunemaitre</surname><given-names>X</given-names></name>
<name><surname>Inoue</surname><given-names>I</given-names></name>
<name><surname>Williams</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Haplotypes of angiotensinogen in essential hypertension</article-title>. <source>Am J Hum Genet</source> <year>1997</year>; <volume>60</volume>: <fpage>1448</fpage>–<lpage>1460</lpage>.</citation>
</ref>
<ref id="bibr7-1470320312440903">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jeunemaitre</surname><given-names>X</given-names></name>
<name><surname>Soubrier</surname><given-names>F</given-names></name>
<name><surname>Kotelevtsev</surname><given-names>YV</given-names></name><etal/>
</person-group>. <article-title>Molecular basis of human hypertension: role of angiotensinogen</article-title>. <source>Cell</source> <year>1992</year>; <volume>71</volume>: <fpage>169</fpage>–<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr8-1470320312440903">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aggarwal</surname><given-names>S</given-names></name>
<name><surname>Dimri</surname><given-names>N</given-names></name>
<name><surname>Tandon</surname><given-names>I</given-names></name>
<name><surname>Agarwal</surname><given-names>S</given-names></name>
</person-group>. <article-title>Preeclampsia in North Indian women: the contribution of genetic polymorphisms</article-title>. <source>J Obstet Gynaecol Res</source> <year>2011</year>; <volume>37</volume>: <fpage>1335</fpage>–<lpage>1341</lpage>.</citation>
</ref>
<ref id="bibr9-1470320312440903">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>T</given-names></name>
<name><surname>Craven</surname><given-names>C</given-names></name>
<name><surname>Lalouel</surname><given-names>JM</given-names></name>
<name><surname>Ward</surname><given-names>K</given-names></name>
</person-group>. <article-title>Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua</article-title>. <source>Am J Obstet Gynecol</source> <year>1999</year>; <volume>180</volume>: <fpage>95</fpage>–<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr10-1470320312440903">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steegers</surname><given-names>EA</given-names></name>
<name><surname>von Dadelszen</surname><given-names>P</given-names></name>
<name><surname>Duvekot</surname><given-names>JJ</given-names></name>
<name><surname>Pijnenborg</surname><given-names>R</given-names></name>
</person-group>. <article-title>Pre-eclampsia</article-title>. <source>Lancet</source> <year>2010</year>; <volume>376</volume>: <fpage>631</fpage>–<lpage>644</lpage>.</citation>
</ref>
<ref id="bibr11-1470320312440903">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aggarwal</surname><given-names>PK</given-names></name>
<name><surname>Jain</surname><given-names>V</given-names></name>
<name><surname>Jha</surname><given-names>V</given-names></name>
</person-group>. <article-title>Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy</article-title>. <source>Hypertens Res</source> <year>2010</year>; <volume>33</volume>: <fpage>473</fpage>–<lpage>477</lpage>.</citation>
</ref>
<ref id="bibr12-1470320312440903">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dissanayake</surname><given-names>VH</given-names></name>
<name><surname>Giles</surname><given-names>V</given-names></name>
<name><surname>Jayasekara</surname><given-names>RW</given-names></name><etal/>
</person-group>. <article-title>A study of three candidate genes for pre-eclampsia in a Sinhalese population from Sri Lanka</article-title>. <source>J Obstet Gynaecol Res</source> <year>2009</year>; <volume>35</volume>: <fpage>234</fpage>–<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr13-1470320312440903">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshida</surname><given-names>A</given-names></name>
<name><surname>Miura</surname><given-names>K</given-names></name>
<name><surname>Nakayama</surname><given-names>D</given-names></name>
<name><surname>Masuzaki</surname><given-names>H</given-names></name>
</person-group>. <article-title>Correlation between preeclampsia and prevalence of polymorphism of angiotensinogen, methyleneteterahydrofolate reductase and factor V, prothrombin genes among Japanese women</article-title>. <source>Acta Med Nagasaki</source> <year>2008</year>; <volume>53</volume>: <fpage>37</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr14-1470320312440903">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knyrim</surname><given-names>E</given-names></name>
<name><surname>Muetze</surname><given-names>S</given-names></name>
<name><surname>Eggermann</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Genetic analysis of the angiotensinogen gene in pre-eclampsia: study of german women and review of the literature</article-title>. <source>Gynecol Obstet Invest</source> <year>2008</year>; <volume>66</volume>: <fpage>203</fpage>–<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr15-1470320312440903">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jenkins</surname><given-names>LD</given-names></name>
<name><surname>Powers</surname><given-names>RW</given-names></name>
<name><surname>Cooper</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women</article-title>. <source>Reprod Sci</source> <year>2008</year>; <volume>15</volume>: <fpage>696</fpage>–<lpage>701</lpage>.</citation>
</ref>
<ref id="bibr16-1470320312440903">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Benedetto</surname><given-names>C</given-names></name>
<name><surname>Marozio</surname><given-names>L</given-names></name>
<name><surname>Ciccone</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Synergistic effect of renin-angiotensin system and nitric oxide synthase genes polymorphisms in pre-eclampsia</article-title>. <source>Acta Obstet Gynecol Scand</source> <year>2007</year>; <volume>86</volume>: <fpage>678</fpage>–<lpage>682</lpage>.</citation>
</ref>
<ref id="bibr17-1470320312440903">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bouba</surname><given-names>I</given-names></name>
<name><surname>Makrydimas</surname><given-names>G</given-names></name>
<name><surname>Kalaitzidis</surname><given-names>R</given-names></name>
<name><surname>Lolis</surname><given-names>DE</given-names></name>
<name><surname>Siamopoulos</surname><given-names>KC</given-names></name>
<name><surname>Georgiou</surname><given-names>I</given-names></name>
</person-group>. <article-title>Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source> <year>2003</year>; <volume>110</volume>: <fpage>8</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr18-1470320312440903">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Procopciuc</surname><given-names>L</given-names></name>
<name><surname>Jebeleanu</surname><given-names>G</given-names></name>
<name><surname>Surcel</surname><given-names>I</given-names></name>
<name><surname>Puscas</surname><given-names>M</given-names></name>
</person-group>. <article-title>Angiotensinogen gene M235T variant and pre-eclampsia in Romanian pregnant women</article-title>. <source>J Cell Mol Med</source> <year>2002</year>; <volume>6</volume>: <fpage>383</fpage>–<lpage>388</lpage>.</citation>
</ref>
<ref id="bibr19-1470320312440903">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kobashi</surname><given-names>G</given-names></name>
<name><surname>Hata</surname><given-names>A</given-names></name>
<name><surname>Shido</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: Implication of a racial difference and significance of an age factor</article-title>. <source>Am J Obstet Gynecol</source> <year>1999</year>; <volume>86</volume>: <fpage>232</fpage>–<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr20-1470320312440903">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roberts</surname><given-names>CB</given-names></name>
<name><surname>Rom</surname><given-names>L</given-names></name>
<name><surname>Moodley</surname><given-names>J</given-names></name>
<name><surname>Pegoraro</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hypertension in Black South African women</article-title>. <source>J Hypertens</source> <year>2004</year>; <volume>22</volume>: <fpage>945</fpage>–<lpage>948</lpage>.</citation>
</ref>
<ref id="bibr21-1470320312440903">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guo</surname><given-names>G</given-names></name>
<name><surname>Wilton</surname><given-names>AN</given-names></name>
<name><surname>Fu</surname><given-names>Y</given-names></name>
<name><surname>Qiu</surname><given-names>H</given-names></name>
<name><surname>Brennecke</surname><given-names>SP</given-names></name>
<name><surname>Cooper</surname><given-names>DW</given-names></name>
</person-group>. <article-title>Angiotensinogen gene variation in a population case-control study of preeclampsia/eclampsia in Australians and Chinese</article-title>. <source>Electrophoresis</source> <year>1997</year>; <volume>18</volume>: <fpage>1646</fpage>–<lpage>1649</lpage>.</citation>
</ref>
<ref id="bibr22-1470320312440903">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>H</given-names></name>
<name><surname>Kang</surname><given-names>JY</given-names></name>
<name><surname>Yoon</surname><given-names>HS</given-names></name><etal/>
</person-group>. <article-title>Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia</article-title>. <source>J Korean Med Sci</source> <year>2004</year>; <volume>19</volume>: <fpage>253</fpage>–<lpage>257</lpage>.</citation>
</ref>
<ref id="bibr23-1470320312440903">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>Y</given-names></name>
<name><surname>Tanemura</surname><given-names>M</given-names></name>
<name><surname>Murakami</surname><given-names>I</given-names></name>
<name><surname>Suzumori</surname><given-names>K</given-names></name>
</person-group>. <article-title>Is angiotensinogen gene polymorphism associated with hypertension in pregnancy?</article-title> <source>Hypertens Pregnancy</source> <year>1999</year>; <volume>18</volume>: <fpage>261</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr24-1470320312440903">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>YJ</given-names></name>
<name><surname>Park</surname><given-names>MH</given-names></name>
<name><surname>Park</surname><given-names>HS</given-names></name>
<name><surname>Lee</surname><given-names>KS</given-names></name>
<name><surname>Ha</surname><given-names>EH</given-names></name>
<name><surname>Pang</surname><given-names>MG</given-names></name>
</person-group>. <article-title>Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source> <year>2004</year>; <volume>116</volume>: <fpage>48</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr25-1470320312440903">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>L</given-names></name>
<name><surname>Crawshaw</surname><given-names>S</given-names></name>
<name><surname>Baker</surname><given-names>PN</given-names></name>
<name><surname>Pipkin</surname><given-names>FB</given-names></name>
<name><surname>Kalsheker</surname><given-names>N</given-names></name>
</person-group>. <article-title>Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia</article-title>. <source>Br J Obstet Gynaecol</source> <year>1999</year>; <volume>106</volume>: <fpage>244</fpage>–<lpage>251</lpage>.</citation>
</ref>
<ref id="bibr26-1470320312440903">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bashford</surname><given-names>MT</given-names></name>
<name><surname>Hefler</surname><given-names>LA</given-names></name>
<name><surname>Vertrees</surname><given-names>TW</given-names></name>
<name><surname>Roa</surname><given-names>BB</given-names></name>
<name><surname>Gregg</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia</article-title>. <source>Am J Obstet Gynecol</source> <year>2001</year>; <volume>184</volume>: <fpage>1345</fpage>–<lpage>1351</lpage>.</citation>
</ref>
<ref id="bibr27-1470320312440903">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tempfer</surname><given-names>CB</given-names></name>
<name><surname>Jirecek</surname><given-names>S</given-names></name>
<name><surname>Riener</surname><given-names>EK</given-names></name><etal/>
</person-group>. <article-title>Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study</article-title>. <source>J Soc Gynecol Investig</source> <year>2004</year>; <volume>11</volume>: <fpage>227</fpage>–<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr28-1470320312440903">
<label>28.</label>
<citation citation-type="journal">
<collab>Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy</collab>. <source>Am J Obstet Gynecol</source> <year>2000</year>; <volume>183</volume>: <fpage>S1</fpage>–<lpage>S22</lpage>.</citation>
</ref>
<ref id="bibr29-1470320312440903">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>JP</given-names></name>
<name><surname>Thompson</surname><given-names>SG</given-names></name>
</person-group>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source> <year>2002</year>; <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>.</citation>
</ref>
<ref id="bibr30-1470320312440903">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>JP</given-names></name>
<name><surname>Thompson</surname><given-names>SG</given-names></name>
<name><surname>Deeks</surname><given-names>JJ</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
</person-group>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <year>2003</year>; <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</citation>
</ref>
<ref id="bibr31-1470320312440903">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Medica</surname><given-names>I</given-names></name>
<name><surname>Kastrin</surname><given-names>A</given-names></name>
<name><surname>Peterlin</surname><given-names>B</given-names></name>
</person-group>. <article-title>Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source> <year>2007</year>; <volume>131</volume>: <fpage>115</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr32-1470320312440903">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zafarmand</surname><given-names>MH</given-names></name>
<name><surname>Nijdam</surname><given-names>ME</given-names></name>
<name><surname>Franx</surname><given-names>A</given-names></name>
<name><surname>Grobbee</surname><given-names>DE</given-names></name>
<name><surname>Bots</surname><given-names>ML</given-names></name>
</person-group>. <article-title>The angiotensinogen gene M235T polymorphism and development of preeclampsia/eclampsia: a meta-analysis and meta-regression of observational studies</article-title>. <source>J Hypertens</source> <year>2008</year>; <volume>26</volume>: <fpage>1726</fpage>–<lpage>1734</lpage>.</citation>
</ref>
<ref id="bibr33-1470320312440903">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barden</surname><given-names>AE</given-names></name>
<name><surname>Beilin</surname><given-names>LJ</given-names></name>
<name><surname>Ritchie</surname><given-names>J</given-names></name>
<name><surname>Walters</surname><given-names>BN</given-names></name>
<name><surname>Graham</surname><given-names>D</given-names></name>
<name><surname>Michael</surname><given-names>CA</given-names></name>
</person-group>. <article-title>Is proteinuric pre-eclampsia a different disease in primigravida and multigravida?</article-title> <source>Clin Sci (Lond)</source> <year>1999</year>; <volume>97</volume>: <fpage>475</fpage>–<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr34-1470320312440903">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gleicher</surname><given-names>N</given-names></name>
<name><surname>Boler</surname><given-names>LR</given-names><suffix>Jr.</suffix></name>
<name><surname>Norusis</surname><given-names>M</given-names></name>
<name><surname>Del Granado</surname><given-names>A</given-names></name>
</person-group>. <article-title>Hypertensive diseases of pregnancy and parity</article-title>. <source>Am J Obstet Gynecol</source> <year>1986</year>; <volume>154</volume>: <fpage>1044</fpage>–<lpage>1049</lpage>.</citation>
</ref>
<ref id="bibr35-1470320312440903">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>T</given-names></name>
<name><surname>Craven</surname><given-names>C</given-names></name>
<name><surname>Nelson</surname><given-names>L</given-names></name>
<name><surname>Lalouel</surname><given-names>JM</given-names></name>
<name><surname>Ward</surname><given-names>K</given-names></name>
</person-group>. <article-title>Angiotensinogen T235 expression is elevated in decidual spiral arteries</article-title>. <source>J Clin Invest</source> <year>1997</year>; <volume>100</volume>: <fpage>1406</fpage>–<lpage>1415</lpage>.</citation>
</ref>
<ref id="bibr36-1470320312440903">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levesque</surname><given-names>S</given-names></name>
<name><surname>Moutquin</surname><given-names>JM</given-names></name>
<name><surname>Lindsay</surname><given-names>C</given-names></name>
<name><surname>Roy</surname><given-names>MC</given-names></name>
<name><surname>Rousseau</surname><given-names>F</given-names></name>
</person-group>. <article-title>Implication of an AGT haplotype in a multigene association study with pregnancy hypertension</article-title>. <source>Hypertension</source> <year>2004</year>; <volume>43</volume>: <fpage>71</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr37-1470320312440903">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hillermann</surname><given-names>R</given-names></name>
<name><surname>Carelse</surname><given-names>K</given-names></name>
<name><surname>Gebhardt</surname><given-names>GS</given-names></name>
</person-group>. <article-title>The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia</article-title>. <source>J Hum Genet</source> <year>2005</year>; <volume>50</volume>: <fpage>415</fpage>–<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr38-1470320312440903">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Feng</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia</article-title>. <source>Am J Obstet Gynecol</source> <year>2006</year>; <volume>195</volume>: <fpage>162</fpage>–<lpage>171</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>